Former Merck VP Nirdosh Jagota settles with SEC on insider trading charge

Merck’s $1.9 billion acquisition of Pandion Therapeutics was a major score for those with stock in the Massachusetts biotech. In one day, the price of Pandion shares surged from $25.63 to $59.81.